Advanced search

Currently, Birgitte Volck holds the position of SVP, Head-Clinical Development & Medical Affairs at Ascendis Pharma A. Dr. Volck is also on the board of Soleno Therapeutics, Inc. and Vaccibody AS. Dr. Volck previously occupied the position of Head-Research & Development at GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development at Swedish Orphan Biovitrum AB, President-Research & Development at Avrobio, Inc., Director-Executive Development at Amgen, Inc., Director-Nordic Medical & Project Director at Genzyme Danmark and Head-Clinical Development & Medical Affairs at Pharmexa A. Birgitte Volck received a doctorate from the University of Copenhagen.

Birgitte Bonnesen served as the President & Chief Executive Officer at Swedbank AB from 2016 to 2019.
Prior to that, she worked at Swedbank AB for over 30 years.
Bonnesen holds an MBA from the Stockholm School of Economics and a graduate degree from the University of Aarhus.

Ms. Birgitte Svendsen is Chief Financial Officer at BioPorto A/S.

Birgitte Lorentzen worked as a Director at SpareBank 1 Helgeland.
She obtained an undergraduate degree from Norges Markedshøyskole and another undergraduate degree from Politihøgskolen.

Birgitte Stephensen is currently working as the Chief Legal Officer & Executive Vice President at Genmab A since 2002.
She graduated from Danmarks Farmaceutiske Universitet.

Birgitte Brekke-Clifton has worked as a Director at The Salvation Army since 2013.

Birgitte Schytte currently works at Medicoindustrien, as Director.

Birgitte Rono is currently working as the Chief Scientific Officer at Evaxion Biotech A.
She started this position in 2021.
In terms of education, Dr. Rono has an undergraduate and graduate degree from the University of Copenhagen.
She also holds a doctorate degree from Copenhagen University Hospital and the National Institutes of Health.

Birgitte Kvalevåg Øversjøen has a current job as an Analyst at DNB Bank ASA (Broker).

Birgitte Tveråen has a current job as a Director at Verdalskalk AS.

Birgitte Vallin is the founder and current Chief Executive Officer of Annette ApS, which is founded in 2017.

Ms. Birgitte Kolrud is on the Board of Directors at Nettpartner AS.
Ms. Kolrud was previously employed as a Senior Investment Manager by Norfund.

Birgitte Nauntofte is currently the Vice Chairman at Steno Diabetes Center A, Director at The Danish Council For Research Policy, and a Member at Denmark Ministry of Education.
She was previously the Chief Executive Officer & Director at Novo Nordisk Fonden, Chairman at The Kennedy Collective Inc, Director at Danmarks Farmaceutiske Universitet, Professor-Clinical Oral Physiology at the University of Copenhagen, and a Member at Noregs forskingsråd and Denmark Ministry of Higher Edcation & Science.
She received her doctorate degree from the University of Copenhagen in 1993.

Birgitte Norup currently works as a Manager-Human Resources at ESS-FOOD A.

Ms. Birgitte Olsen, CFA, is a Lead Portfolio Manager at Bellevue Asset Management AG.
She is also a Senior Portfolio Manager for European Equities.
She joined the firm in 2008.
She previously spent over nine years at Generali Investments in Cologne as Deputy Head of Equities, managing European portfolios and thematic funds.

Birgitte Brinch Madsen is currently the Vice Chairman at DEIF A.
She also holds several non-executive director positions, including at John Wood Group Plc, Arkil Holding A, Investeringsforeningen Danske Invest, Investeringsforeningen Danske Invest Select, and Danske Invest Select.
Previously, she worked as the Director of Energy & Industry Business at COWI A and as the Chief Technical Officer at Maersk A and Maersk FPSOs A.
She graduated from the University of Copenhagen.

Birgitte Schou currently works at Schou Co. A, as Director and HP Schou Holding A, as Director.

Birgitte Skade currently works as a Director at BHS Logistics A.

Birgitte Rønnow has founded Terranol A in 2007, where she currently holds the title of Chief Executive Officer.
She previously worked as a Principal at DuPont Nutrition Biosciences ApS.
Dr. Rønnow earned a doctorate degree from the University of Copenhagen in 1992.

Birgitte Skou Holck-Andersen is a Director of ACE BioSciences A/S and NatImmune A/S and Deputy Chairman of ZGene A/S.
She is an Investment Manager of A/S Dansk Erhvervsinvestering.
Dr. Holck-Andersen joined A/S Dansk Erhvervsinvestering in 2001.
She has 10 years of experience in the biotech and healthcare industries.
Dr. Holck-Andersen received an MSc degree in 1984 and a PhD in 1987 from the Technical University of Denmark.

Birgitte Lund is currently a Director at Hi3G Denmark ApS.
Previously, she was a Director at NetDesign A.

Birgitte Holst is currently the General Manager & Director at Axel Muusfeldts Fond.

Birgitte Bøgh-Sørensen was the founder of Orifarm Group A, where she held the title of Co-President.
She is currently a Director at Orifarm A since 2001 and a Director at Orifarm Supply Holding AS.

Birgitte Engebretsen is currently the Chief Executive Officer at Telenor Networks Holding AS, Telenor Norge AS, and Director at Hiddn Security AS.
She is also the Director at Telenor Maritime.
AS since 2020.
Previously, she served as an Independent Director at DNA Plc, Director at Nettverk AS, and Director-Sales & Marketing at Phonect.
AS from 2014 to 2015.

Birgitte Lundeby Kolstad has worked as a Senior Associate at HitecVision Private Equity AS since 2020 and as a Senior Financial Analyst at Copenhagen Infrastructure Partners P since 2018.

Birgitte Engleder is currently the Managing Director at Engel Gesellschaft mbH, a Member-Supervisory Board at KURIER Beteiligungs-AG, and a Managing Partner at EBS Beteiligungs GmbH.
Previously, she was an Independent Member-Supervisory Board at Oberbank AG from 2006 to 2011.